Renard Charity

Renard has extensive experience as an advisor to large established enterprises and nonprofits seeking to identify, evaluate, and harness growth opportunities as well as with entrepreneurs and investors looking to develop early-stage startups. His work with international companies and investors, both venture and private equity, covers a broad array of technologies and sectors, including medical devices, supplies, manufacturing and supply chains, CROs, health services, and healthcare IT/analytics.

Earlier in his career, Renard worked at The Boston Consulting Group in their healthcare practice. Prior to FSI, Renard worked at GE where he helped orchestrate an IPO spinout of a $15B business unit as the marketing head of its largest division. Prior to GE, Renard worked at Boston Scientific, as head of strategy, as well as in several divisional marketing and business development capacities, at a time during which the company tripled its market value. Prior to business school Renard worked in Morgan Stanley’s M&A Department.

Renard currently serves on the Board of the Coulter Translational Research Board at the University of Michigan and the Board of Advisors for the Eshelman Institute for Innovation at the University of North Carolina where he also serves as the chairman of the Board for the Institute’s PowerUp initiative which partners with HBCUs to empower underrepresented talent and enable innovation to create startups with diverse CEOs. He has also served on of the Board of Cheetah Medical (sold to Baxter) and HistoSonics.